Pharmaceuticals Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1AMLX Amylyx Pharmaceuticals
163.17
 0.12 
 4.98 
 0.60 
2RPRX Royalty Pharma Plc
0.94
 0.05 
 1.71 
 0.08 
3CRMD CorMedix
0.52
 0.09 
 6.21 
 0.58 
4NVO Novo Nordisk AS
0.5
 0.01 
 3.02 
 0.04 
5INVA Innoviva
0.47
 0.31 
 1.13 
 0.35 
6LLY Eli Lilly and
0.42
(0.03)
 3.30 
(0.10)
7MRK Merck Company
0.4
(0.09)
 2.25 
(0.20)
8ZTS Zoetis Inc
0.38
(0.03)
 2.12 
(0.05)
9ARVN Arvinas
0.38
(0.02)
 5.17 
(0.09)
10NVS Novartis AG ADR
0.35
 0.05 
 1.55 
 0.08 
11PFE Pfizer Inc
0.35
(0.05)
 1.91 
(0.10)
12PBH Prestige Brand Holdings
0.34
(0.01)
 1.68 
(0.02)
13BMY Bristol Myers Squibb
0.32
(0.19)
 2.07 
(0.39)
14GSK GlaxoSmithKline PLC ADR
0.31
 0.02 
 2.00 
 0.04 
15HRMY Harmony Biosciences Holdings
0.3
(0.03)
 2.31 
(0.06)
16JNJ Johnson Johnson
0.29
(0.06)
 1.60 
(0.10)
17AZN AstraZeneca PLC ADR
0.28
(0.03)
 1.88 
(0.06)
18AMPH Amphastar P
0.22
(0.06)
 2.49 
(0.16)
19OGN Organon Co
0.21
(0.11)
 5.21 
(0.56)
20SNY Sanofi ADR
0.21
(0.09)
 1.87 
(0.17)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.